BELANO Medical - The Micro­biotics Company

Press

Novel bioactive from Lactobacillus brevis DSM17250 to stimulate the growth of Staphylococcus epidermidis: a pilot study

Novel bioactive from Lactobacillus brevis DSM17250 to stimulate the growth of Staphylococcus epidermidis: a pilot study mehr lesen

Commensal skin micro­biota plays an important role in both influencing the immune response of the skin and acting as a

Novel bioactive from Lactobacillus brevis DSM17250 to stimulate the growth of Staphylococcus epidermidis: a pilot study mehr lesen

Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study.

Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study. mehr lesen

Reducing the amount of Helico­bacter pylori in the stomach by selective bacterial–bacterial cell inter­action was sought as an effective and

Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study. mehr lesen

Scroll to Top
Scroll to Top